Publications by authors named "Markus Barden"

Claim this Profile
D
Development of antigen multimers for detection and evaluation of CAR T cells.
Rasmus U W Friis, Maria Ormhøj, Cecilie S Krüger-Jensen, Carlos Rodriguez Pardo, Hólmfridur Rósa Halldórsdóttir, Markus Barden

Cancer Immunol Immunother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CAR T cells in solid tumors: resistance mechanisms].
Markus Barden, Astrid Holzinger, Hinrich Abken

Inn Med (Heidelb)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor (CAR) T Cells Releasing Soluble SLAMF6 Isoform 2 Gain Superior Anti-Cancer Cell Functionality in an Auto-Stimulatory Fashion.
Dennis Christoph Harrer, Tim Schlierkamp-Voosen, Markus Barden, Hong Pan, Maria Xydia

Cells· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.
Markus Barden, Patrick Ronan Elsenbroich, Vivian Haas, Moritz Ertelt, Philip Pervan

J Immunother Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy.
Jeremy G Baldwin, Christoph Heuser-Loy, Tanmoy Saha, Roland C Schelker, Dragana Slavkovic-Lukic, Markus Barden

Cell· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma.
Krasimira Aleksandrova, Jana Leise, Christoph Priesner, Murat Aktas, Michael Apel, Markus Barden

Front Immunol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ectopic PU.1 Expression Provides Chimeric Antigen Receptor (CAR) T Cells with Innate Cell Capacities Including IFN-β Release.
Dennis Christoph Harrer, Matthias Eder, Markus Barden, Hong Pan, Wolfgang Herr

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic CAR T cell purification using an anti-G4S linker antibody.
Dennis Christoph Harrer, Sin-Syue Li, Marcell Kaljanac, Valerie Bezler, Markus Barden

J Immunol Methods· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine-tuning the antigen sensitivity of CAR T cells: emerging strategies and current challenges.
Dennis Christoph Harrer, Sin-Syue Li, Marcell Kaljanac, Markus Barden, Hong Pan

Front Immunol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
Markus Barden, Astrid Holzinger, Lukas Velas, Marianna Mezősi-Csaplár, Árpád Szöőr

Front Immunol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop.
Dennis Christoph Harrer, Charlotte Schenkel, Valerie Bezler, Marcell Kaljanac, Jordan Hartley, Markus Barden

Cells· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL12 integrated into the CAR exodomain converts CD8 T cells to poly-functional NK-like cells with superior killing of antigen-loss tumors.
Andreas Hombach, Markus Barden, Lisa Hannappel, Markus Chmielewski, Gunter Rappl

Mol Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The growing world of CAR T cell trials: a systematic review.
Astrid Holzinger, Markus Barden, Hinrich Abken

Cancer Immunol Immunother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis